Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection

Beom Kyung Kim, Jun Yong Park, Do Young Kim, Ja Kyung Kim, Kyung Sik Kim, Jin Sub Choi, Byung Soo Moon, Kwang Hyub Han, Chae Yoon Chon, Young Myoung Moon, Sang Hoon Ahn

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Background: Elevated serum hepatitis B virus (HBV) DNA increases the development of hepatocellular carcinoma (HCC). Rather than instantaneous DNA level, the duration of persistent HBV replication is more important in carcinogenesis. Nevertheless, most investigators evaluated the DNA level at study entry. We assessed the effects of persistently detectable serum HBV DNA on HCC recurrence. Patients and methods: We included 230 consecutive patients undergoing curative resection between 2000 and 2006. Patients who had antiviral therapy (at diagnosis or during follow-up), fluctuating DNA (cut-off value: 100000 copies/ml) or recurrence within 12 months of resection were excluded. Ultimately, 157 were enrolled: 89 (non-viraemia group) had consistently negative DNA (<100000 copies/ml), while 68 (viraemia group) had consistently positive DNA (>100000 copies/ml). Serum DNA level, biochemical tests, α-foetoprotein (AFP) and liver dynamic computed tomography were obtained every 3 months after surgery. Results: There were no significant differences in age, gender, liver function, histology, AFP, tumour stages or follow-up duration between the two groups. During follow-up (median: 35 months), patients in the non-viraemia group had a lower 5-year cumulative recurrence rate (54.7%) than those in the viraemia group (72.9% P = 0.043). In multivariate analysis, sustained viraemia (P = 0.041) increased recurrence independently. Conclusions: Persistent viraemia increased recurrence independently after surgery. To prevent long-term recurrences, antiviral therapy should be initiated in those with detectable serum HBV DNA.

Original languageEnglish
Pages (from-to)393-401
Number of pages9
JournalLiver International
Volume28
Issue number3
DOIs
Publication statusPublished - 2008 Mar 1

Fingerprint

Hepatitis B
Hepatocellular Carcinoma
Recurrence
DNA
Hepatitis B virus
Viremia
Serum
Antiviral Agents
Fetal Proteins
Liver
Virus Replication
Histology
Carcinogenesis
Multivariate Analysis
Tomography
Research Personnel
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Hepatology

Cite this

Kim, Beom Kyung ; Park, Jun Yong ; Kim, Do Young ; Kim, Ja Kyung ; Kim, Kyung Sik ; Choi, Jin Sub ; Moon, Byung Soo ; Han, Kwang Hyub ; Chon, Chae Yoon ; Moon, Young Myoung ; Ahn, Sang Hoon. / Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. In: Liver International. 2008 ; Vol. 28, No. 3. pp. 393-401.
@article{8770e9afea914de4b4b900d71dff4b06,
title = "Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection",
abstract = "Background: Elevated serum hepatitis B virus (HBV) DNA increases the development of hepatocellular carcinoma (HCC). Rather than instantaneous DNA level, the duration of persistent HBV replication is more important in carcinogenesis. Nevertheless, most investigators evaluated the DNA level at study entry. We assessed the effects of persistently detectable serum HBV DNA on HCC recurrence. Patients and methods: We included 230 consecutive patients undergoing curative resection between 2000 and 2006. Patients who had antiviral therapy (at diagnosis or during follow-up), fluctuating DNA (cut-off value: 100000 copies/ml) or recurrence within 12 months of resection were excluded. Ultimately, 157 were enrolled: 89 (non-viraemia group) had consistently negative DNA (<100000 copies/ml), while 68 (viraemia group) had consistently positive DNA (>100000 copies/ml). Serum DNA level, biochemical tests, α-foetoprotein (AFP) and liver dynamic computed tomography were obtained every 3 months after surgery. Results: There were no significant differences in age, gender, liver function, histology, AFP, tumour stages or follow-up duration between the two groups. During follow-up (median: 35 months), patients in the non-viraemia group had a lower 5-year cumulative recurrence rate (54.7{\%}) than those in the viraemia group (72.9{\%} P = 0.043). In multivariate analysis, sustained viraemia (P = 0.041) increased recurrence independently. Conclusions: Persistent viraemia increased recurrence independently after surgery. To prevent long-term recurrences, antiviral therapy should be initiated in those with detectable serum HBV DNA.",
author = "Kim, {Beom Kyung} and Park, {Jun Yong} and Kim, {Do Young} and Kim, {Ja Kyung} and Kim, {Kyung Sik} and Choi, {Jin Sub} and Moon, {Byung Soo} and Han, {Kwang Hyub} and Chon, {Chae Yoon} and Moon, {Young Myoung} and Ahn, {Sang Hoon}",
year = "2008",
month = "3",
day = "1",
doi = "10.1111/j.1478-3231.2007.01625.x",
language = "English",
volume = "28",
pages = "393--401",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "3",

}

Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. / Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Kim, Ja Kyung; Kim, Kyung Sik; Choi, Jin Sub; Moon, Byung Soo; Han, Kwang Hyub; Chon, Chae Yoon; Moon, Young Myoung; Ahn, Sang Hoon.

In: Liver International, Vol. 28, No. 3, 01.03.2008, p. 393-401.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection

AU - Kim, Beom Kyung

AU - Park, Jun Yong

AU - Kim, Do Young

AU - Kim, Ja Kyung

AU - Kim, Kyung Sik

AU - Choi, Jin Sub

AU - Moon, Byung Soo

AU - Han, Kwang Hyub

AU - Chon, Chae Yoon

AU - Moon, Young Myoung

AU - Ahn, Sang Hoon

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Background: Elevated serum hepatitis B virus (HBV) DNA increases the development of hepatocellular carcinoma (HCC). Rather than instantaneous DNA level, the duration of persistent HBV replication is more important in carcinogenesis. Nevertheless, most investigators evaluated the DNA level at study entry. We assessed the effects of persistently detectable serum HBV DNA on HCC recurrence. Patients and methods: We included 230 consecutive patients undergoing curative resection between 2000 and 2006. Patients who had antiviral therapy (at diagnosis or during follow-up), fluctuating DNA (cut-off value: 100000 copies/ml) or recurrence within 12 months of resection were excluded. Ultimately, 157 were enrolled: 89 (non-viraemia group) had consistently negative DNA (<100000 copies/ml), while 68 (viraemia group) had consistently positive DNA (>100000 copies/ml). Serum DNA level, biochemical tests, α-foetoprotein (AFP) and liver dynamic computed tomography were obtained every 3 months after surgery. Results: There were no significant differences in age, gender, liver function, histology, AFP, tumour stages or follow-up duration between the two groups. During follow-up (median: 35 months), patients in the non-viraemia group had a lower 5-year cumulative recurrence rate (54.7%) than those in the viraemia group (72.9% P = 0.043). In multivariate analysis, sustained viraemia (P = 0.041) increased recurrence independently. Conclusions: Persistent viraemia increased recurrence independently after surgery. To prevent long-term recurrences, antiviral therapy should be initiated in those with detectable serum HBV DNA.

AB - Background: Elevated serum hepatitis B virus (HBV) DNA increases the development of hepatocellular carcinoma (HCC). Rather than instantaneous DNA level, the duration of persistent HBV replication is more important in carcinogenesis. Nevertheless, most investigators evaluated the DNA level at study entry. We assessed the effects of persistently detectable serum HBV DNA on HCC recurrence. Patients and methods: We included 230 consecutive patients undergoing curative resection between 2000 and 2006. Patients who had antiviral therapy (at diagnosis or during follow-up), fluctuating DNA (cut-off value: 100000 copies/ml) or recurrence within 12 months of resection were excluded. Ultimately, 157 were enrolled: 89 (non-viraemia group) had consistently negative DNA (<100000 copies/ml), while 68 (viraemia group) had consistently positive DNA (>100000 copies/ml). Serum DNA level, biochemical tests, α-foetoprotein (AFP) and liver dynamic computed tomography were obtained every 3 months after surgery. Results: There were no significant differences in age, gender, liver function, histology, AFP, tumour stages or follow-up duration between the two groups. During follow-up (median: 35 months), patients in the non-viraemia group had a lower 5-year cumulative recurrence rate (54.7%) than those in the viraemia group (72.9% P = 0.043). In multivariate analysis, sustained viraemia (P = 0.041) increased recurrence independently. Conclusions: Persistent viraemia increased recurrence independently after surgery. To prevent long-term recurrences, antiviral therapy should be initiated in those with detectable serum HBV DNA.

UR - http://www.scopus.com/inward/record.url?scp=39549083447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39549083447&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2007.01625.x

DO - 10.1111/j.1478-3231.2007.01625.x

M3 - Article

C2 - 18028321

AN - SCOPUS:39549083447

VL - 28

SP - 393

EP - 401

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 3

ER -